Contact

Contact

New York Office:

757 Third Avenue
24th Floor
New York, NY 10017
Tel: 212-753-1991
Fax: 212-753-7730

*Your Name:
*Name:
Title:
Company:
Industry:
Phone:
*Email:
Request:
Comments:

Recent Firm News

  • Kevin M. Halpin joins Brooks, Houghton & Company, Inc. - July 31, 2019

    New York, NY  Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that Kevin M. Halpin has joined the firms Investment Banking team as a Managing Director.


  • BHC Serves as M&A Adviser to Generex Biotechnology Corporation on Final Tranche Acquisition - November 5, 2018

    Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the second and final tranche acquisition of remaining operating assets


  • BHC Serves as M&A Adviser to Generex Biotechnology Corporation on Acquisition of Assets - October 11, 2018

    Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the first tranche acquisition of certain operating assets from Veneto


Brooks, Houghton & Company, Inc.
757 Third Avenue • 24th Floor • New York, NY 10017 • Phone: (212) 753-1991 • Fax: (212) 753-7730 • info@brookshoughton.com
Securities offered through Brooks Houghton Securities , Inc.
Member FINRA and SIPC

Website Developed by: Smart Interactive Media